HMS Capital Management’s Merck MRK Stock Holding History

HMS Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-734	Closed	-$64K	–	137
2019 Q4	$64K	Buy	+734	New	+$60.3K	0.03%	166
2019 Q3	–	Sell	-734	Closed	-$59K	–	266
2019 Q2	$59K	Buy	+734	New	+$56.2K	0.03%	210
2019 Q1	–	Sell	-734	Closed	-$53K	–	203
2018 Q4	$53K	Hold	734	–	–	0.03%	177
2018 Q3	$50K	Buy	+734	New	+$46.8K	0.02%	195

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HMS Capital Management's MRK Position: Q4 2022 in Review

HMS Capital Management sold out of Merck (MRK) in Q4 2022, closing a stake of 2,660 shares — an estimated $229K sold.

HMS Capital Management first reported a position in MRK in Q2 2018 and held it in 7 quarters. The position peaked at $368K in Q4 2018. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

HMS Capital Management reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
HMS Capital Management sold 2,660 Merck shares in Q4 2022, an estimated $229K.
HMS Capital Management first reported a position in Merck in Q2 2018 and held it in 7 quarters.
HMS Capital Management's Merck position peaked at $368K in Q4 2018.
3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on HMS Capital Management's 13F filing for Q4 2022, filed 23 Jan 2023.